Alembic Global analyst Peter Skibitski upgrades AeroVironment (NASDAQ:AVAV) from Neutral to Overweight.
Alembic Global Upgrades AeroVironment to Overweight
Alembic Global analyst Peter Skibitski upgrades AeroVironment (NASDAQ:AVAV) from Neutral to Overweight.
Related Posts
Thanks, Biden … Gas Prices Are Now Down To The Same Price They Were A Year Ago
A few months ago, gas prices hit record highs as inflation looked unstoppable. But since then, gas prices have fallen significantly and are now back down to what they were one year ago.
Well, almost.
Where Apollo Global Management Stands With Analysts
Over the past 3 months, 8 analysts have published their opinion on Apollo Global Management (NYSE:APO) stock. These…
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,900 Today
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 19.58% on an annualized basis producing an average annual return of 31.2%. Currently, CRISPR Therapeutics has a market capitalization of $5.57 billion.